Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.57 USD | -2.82% | -11.46% | +22.72% |
May. 15 | Solid Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.72% | 295M | |
+9.88% | 118B | |
+10.24% | 106B | |
-11.33% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.68% | 15.97B | |
+6.83% | 14.03B | |
+17.92% | 11.67B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Citigroup Starts Coverage on Solid Biosciences With Buy Rating, $16 Price Target